2-Bromo-3'-chloropropiophenone
- CAS NO.:34911-51-8
- Empirical Formula: C9H8BrClO
- Molecular Weight: 247.52
- MDL number: MFCD03701150
- EINECS: 252-282-1
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-09-25 14:54:50
What is 2-Bromo-3'-chloropropiophenone?
Chemical properties
Yellow Oil
The Uses of 2-Bromo-3'-chloropropiophenone
It used as an important intermediate for raw material and intermediate used in organic synthesis agrochemical, pharmaceutical and dyestuff field.
Definition
2-Bromo-3'-chloropropiophenone (BCP), a yellow oil, is an intermediate used in the synthesis of bupropion and is also found as an impurity of bupropion hydrochloride. Bupropion is a second-generation antidepressant that was originally approved by the United States Food and Drug Administration (FDA) in 1985. It is a norepinephrine and dopamine transporter inhibitor and an antagonist at neuronal nicotinic acetylcholine receptors. Bupropion is also approved for smoking cessation[1].
Safety
The current United States Pharmacopeia (USP) specification is for no more than 0.1% BCP in the bupropion hydrochloride monograph. The Material Safety Data Sheet from a manufacturer indicates that BCP is irritating to the eyes, respiratory system, and skin. 2-Bromo-3'-chloropropiophenone was mutagenic with S9 metabolic activation, increasing the mutant frequencies in a concentration-dependent manner, up to 22- and 145-fold induction over the controls in Salmonella strains TA100 and TA1535, respectively. BCP was also positive in the in vitro micronucleus assay, resulting in up to 3.3- and 5.1-fold increase of micronucleus frequency for treatments in the absence and presence of S9, respectively; and 9.9- and 7.4-fold increase of aneuploidies without and with S9, respectively. The addition of N-acetyl-l-cysteine, an antioxidant, reduced the genotoxicity of BCP in both assays. Further studies showed that BCP treatment resulted in induction of reactive oxygen species (ROS) in the TK6 cells. The results suggest that BCP is mutagenic, clastogenic, and aneugenic, and that these activities are mediated via generation of reactive metabolites[1].
References
[1] Meng, Fanxue , et al. "Genotoxicity of 2-bromo-3′-chloropropiophenone." Toxicology & Applied Pharmacology 270.2(2013):158-163.
Properties of 2-Bromo-3'-chloropropiophenone
Boiling point: | 148-148.5 °C(Press: 9 Torr) |
Density | 1.532 |
refractive index | 1.5770 |
storage temp. | Refrigerator, Under Inert Atmosphere |
solubility | Soluble in acetonitrile, chloroform, dichloromethane and ethyl acetate. |
form | Liquid |
color | Colorless to pale yellow |
InChI | InChI=1S/C9H8BrClO/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6H,1H3 |
CAS DataBase Reference | 34911-51-8(CAS DataBase Reference) |
Safety information for 2-Bromo-3'-chloropropiophenone
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. P405:Store locked up. |
Computed Descriptors for 2-Bromo-3'-chloropropiophenone
InChIKey | OFNMQTRHMBQQEA-UHFFFAOYSA-N |
SMILES | C(C1=CC=CC(Cl)=C1)(=O)C(Br)C |
Abamectin manufacturer
KARUNESH REMEDIES
Vedzon Healthcare Pvt Ltd
Chemikos Laboratories Pvt Ltd
Vachichem
Rivashaa Agrotech Biopharma Pvt. Ltd.
Vandana Chemicals
Lavybens Pharma
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
2-Bromo -3'-chloropropiophenone 98%View Details
34911 -51 -8 -
34911-51-8 99.76View Details
34911-51-8 -
2-Bromo-3'-chloropropiophenone 34911-51-8 98%View Details
34911-51-8 -
2-Bromo-3'-chloropropiophenone 98%View Details
-
2-Bromo-3’-Chloropropiophenone (Intermediate of Bupropion ) Complies as per MonographView Details
34911-51-8 -
2-bromo-3’-chloropropiophenone 99%View Details
-
34911-51-8 2-Bromo-3'-chloropropiophenone 98%View Details
34911-51-8 -
34911-51-8 2-Bromo-3'-chloropropiophenone 98%View Details
34911-51-8